rdf:type |
|
lifeskim:mentions |
|
pubmed:dateCreated |
1999-4-20
|
pubmed:abstractText |
Adjuvant therapy has shown to be of significant benefit in patients with breast cancer. Among the possibilities to further improve the results, preoperative chemotherapy is a promising tool. So far, we have treated 178 patients and found that downstaging permits breast conservation in 60% of patients who would otherwise undergo mastectomy. The significance of this method for further improvement of survival has to await results of ongoing trials.
|
pubmed:language |
ger
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0044-409X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
123 Suppl 5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
147-50
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10063601-Adult,
pubmed-meshheading:10063601-Aged,
pubmed-meshheading:10063601-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10063601-Breast Neoplasms,
pubmed-meshheading:10063601-Combined Modality Therapy,
pubmed-meshheading:10063601-Female,
pubmed-meshheading:10063601-Humans,
pubmed-meshheading:10063601-Lymphatic Metastasis,
pubmed-meshheading:10063601-Middle Aged,
pubmed-meshheading:10063601-Neoadjuvant Therapy,
pubmed-meshheading:10063601-Neoplasm Staging,
pubmed-meshheading:10063601-Survival Rate
|
pubmed:year |
1998
|
pubmed:articleTitle |
[Neoadjuvant chemotherapy of patients with breast carcinoma].
|
pubmed:affiliation |
Klinische Abteilung für Allgemeinchirurgie, Universitätsklinik für Chirurgie, Wien.
|
pubmed:publicationType |
Journal Article,
English Abstract
|